Hester Biosciences Ltd posts consolidated Q2FY22 net profit of Rs. 11.12 crore

Hester Biosciences Limited has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 64.086 crores during the period ended September 30, 2021 as compared to Rs. 62.534 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 11.128 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 11.019 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 13.08 for the period ended September 30, 2021 as compared to Rs. 12.95 for the period ended June 30, 2021.

Financials	Q2 FY2022	Q1 FY2022	% Change
Total Income	₹ 64.086 crs	₹62.534 crs	2.48%
Net Profit	₹11.128 crs	₹11.019 crs	0.99%
EPS	₹13.08	₹12.95	1.00%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 64.086 crores during the period ended September 30, 2021 as compared to Rs.53.653 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.11.128 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.6.682 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.13.08 for the period ended September 30, 2021 as compared to Rs.7.85 for the period ended September 30, 2020.

Financials	Q2 FY2022	Q2 FY2021	% Change
Total Income	₹ 64.086 crs	₹53.653 crs	19.45%
Net Profit	₹11.128 crs	₹6.682 crs	66.54%
EPS	₹13.08	₹7.85	66.62%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.126.620 crores during the 6 Months period ended September 30, 2021 as compared to Rs.94.20 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.22.147 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.11.732 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.26.03 for the 6 Months period ended September 30, 2021 as compared to Rs.13.79 for the 6 Months period ended September 30, 2020.

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹126.620 crs	₹94.20 crs	34.42%
Net Profit	₹22.147 crs	₹11.732 crs	88.77%
EPS	₹26.03	₹13.79	88.76%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 2466.50 as compared to the previous close of Rs. 2470.95. The total number of shares traded during the day was 781 in over 393 trades.

The stock hit an intraday high of Rs. 2534.40 and intraday low of 2459.40. The net turnover during the day was Rs. 1945592.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q2FY22 H1FY22 ResultUpdate